Granahan Investment Management’s Beam Therapeutics BEAM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-136,137	Closed	-$4.17M	–	176
2023 Q1	$4.17M	Sell	136,137 -27,653	-17%	-$1.09M	0.13%	137
2022 Q4	$6.41M	Buy	163,790 +53,355	+48%	+$2.39M	0.2%	115
2022 Q3	$5.26M	Buy	110,435 +29,507	+36%	+$1.68M	0.17%	125
2022 Q2	$3.13M	Sell	80,928 -27,299	-25%	-$1.09M	0.11%	143
2022 Q1	$6.2M	Buy	108,227 +24,835	+30%	+$1.63M	0.15%	124
2021 Q4	$6.65M	Sell	83,392 -7,448	-8%	-$638K	0.14%	136
2021 Q3	$7.9M	Sell	90,840 -11,683	-11%	-$1.17M	0.15%	127
2021 Q2	$13.2M	Buy	102,523 +5,932	+6%	+$473K	0.25%	95
2021 Q1	$7.73M	Sell	96,591 -17,467	-15%	-$1.66M	0.16%	112
2020 Q4	$9.31M	Buy	114,058 +18,773	+20%	+$923K	0.21%	95
2020 Q3	$2.35M	Sell	95,285 -1,313	-1%	-$32.6K	0.08%	145
2020 Q2	$2.71M	Sell	96,598 -1,678	-2%	-$36.2K	0.1%	139
2020 Q1	$1.77M	Buy	+98,276	New	+$2.14M	0.1%	142